PTPA and neoplasm: Given the important role of tumor cell quiescence as a driver of tumor radioresistance and recurrence in cancer patients [55], inhibiting PP2A may represent a viable means of promoting tumor radiosensitivity by driving cells in the G0 phase of the cell cycle to undergo mitosis.